About
- Name
- ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)
- Index tracked
- Hang Seng Biotech PR
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 0.8279 (08/19/2026)
- Issued units
- 5.77B (08/20/2026)
- Listing date
- Sep 29, 2021
- Sponsor
- China Asset Mgmt Co.,Ltd
- Custodian
- Agricultural Bank of China Ltd
ETF Documents
Last updatedType
03/31/2026Annual Report
09/01/2025Semi Annual Report
07/20/2026Prospectus
07/21/2026Quarterly Report